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Carcinogenicity of pan masala, a dry powdered chewing
mixture of areca nut, catechu, lime, spices and flavoring
agents was evaluated by means of the long-term animal
bio-assay 6- to 7-week old male and female S/RVCri mice
were divided randomly into intermediate and lifetime expo-
sure groups and fed normal diet without pan masala—(zero
dose) or diet containing 2.5% and 5% pan masala. Animals in
the intermediate-exposure group (n 5 10/gender/dose group)
were killed after 6, 12 or 18 months of treatment, while those
in the lifetime-exposure group (n 5 54/gender/dose group)
were killed when moribund or at the termination of the
experiment at 24 months. Several tissues were processed for
histopathological examination. The body weight and survival
rate of mice fed pan masala were lower than that of the
controls. Histopathological observations of tissues from con-
trol animals did not reveal any neoplastic alterations. How-
ever, lifetime feeding of pan masala induced adenoma of the
liver, stomach, prostate and sebaceous glands, also forestom-
ach papilloma, liver hamartoma, hepatoma and hemangi-
oma, carcinoma of the forestomach, adenocarcinoma of the
lung and liver, and testicular lymphoma. Neoplastic lesions
appeared mainly in the liver (n 5 13), stomach (n 5 3) and
lung (n 5 8). Lung adenocarcinoma, the most frequent malig-
nant tumor type, was observed in 2/120 mice in the interme-
diate-exposure group and in 8/216 animals in the lifetime-
exposure group. Statistical analysis of tumor-induction data
revealed a significant dose-related increase in lung adenocar-
cinomas but not in liver and stomach neoplasms indicating
that lung is the major target tissue for the carcinogenic action
of pan masala. Int. J. Cancer 83:679–684, 1999.
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Nearly 2 decades ago, pan masala, a dry powdered chewing
mixture of areca nut, catechu, lime, unspecified spices and flavor-
ing agents, was introduced into the Indian market. Presently, 2
types of chewing products are available, i.e., ‘‘pan masala’’ without
tobacco, and ‘‘gutkha,’’ which is a mixture of pan masala and
tobacco. Aggressive product promotion through the mass media
has contributed to the immense popularity of the ready-to-use
chewing products in the Indian subcontinent. Pan masala is popular
not only with males but also among women and children who
generally refrain from tobacco use in any form.
Areca nut, the major constituent of pan masala, has been shown
to exhibit clastogenic, mutagenic, genotoxic and carcinogenic
properties in different experimental systems (Suri et al., 1971;
Ranadive et al., 1976; IARC, 1985; Panigrahi and Rao, 1986; Dave
et al., 1992). Habitual use of areca nut is causally associated with
increased risk of human oral pre-cancer and cancer (Chin and Lee,
1970; IARC, 1985; Sinor et al., 1990). Catechu, another constituent
of pan masala, was found to possess strong mutagenic (Stich et al.,
1983) and clastogenic (Giri et al., 1987) activity, while lime is
known to cause irritation and hyperplasia of the oral mucosa
(Dunham et al., 1966).
In other studies, pan masala per se was reported to exhibit
genotoxic and mutagenic properties in several short-term assays
(Adhvaryu et al., 1989; Bagwe et al., 1990; Mukherjee and Giri,
1991; Polasa et al., 1993). Chronic feeding of pan masala was
shown to impair liver function in rats and to affect the mouse
germinal cells by inducing sperm-head abnormalities (Mukherjee
et al., 1991; Sarma et al., 1992). Increased cytogenetic damage was
also reported in the peripheral-blood lymphocytes and exfoliated
buccal mucosal cells of pan masala consumers (Dave et al., 1991).
Moreover, pan-masala chewing has been linked to the development
of oral sub-mucous fibrosis, a condition known to pre-dispose to
cancer (Anuradha and Devi, 1993). These observations provided
compelling evidence for evaluation of the carcinogenicity of pan
masala. We have reported that an extract of pan masala exerts
tumor promoting and progressor activities in the skin, stomach and
esophagus of 2 different mouse models (Ramchandani et al., 1998).
In the present study, the implications of chronic pan-masala usage
were elucidated in the long-term carcinogenicity assay using
another mouse model.
MATERIAL AND METHODS
Test substance
A market survey on the rate of purchase of different brands of
pan masala was conducted in different parts of Mumbai, India. The
brand with the highest sale was then used for carcinogenicity
testing. The product was purchased in bulk, so as to avoid
batch-to-batch variation, and was stored at 220°C until use.
Diet preparation
Dry, finely powdered pan masala was mixed with standard
animal feed at concentrations of 10%, 5% and 2.5%. The feed
containing pan masala was pelleted, sealed in air-tight plastic bags
and stored at 0 to 4°C until use. Fresh diet was prepared once every
8 weeks.
Animals and maintenance
Inbred Swiss mice of the S/RVCri strain used in the present study
were initially obtained from the Rockefeller Institute, New York,
and were random bred at the Virus Research Institute, Pune, India.
The breeding stock was transferred to the animal colony of the
Cancer Research Institute, Mumbai, India, in 1953. A total of 554
mice of both sexes, aged 6 to 7 weeks, were provided by the animal
house of the Cancer Research Institute, Mumbai, India. Animals of
the same sex were randomly assigned to different dose groups, and
were housed 5 to a cage in an air-conditioned animal house
(temperature 21 6 1°C, humidity 55 to 60%, constant 12-hr
light/dark cycle) and were fed normal diet without pan masala or
mouse feed containing pan masala. Water was given ad libitum.
Carcinogenicity testing of pan masala
Dose selection. Determination of maximum tolerated dose
(MTD) has to be undertaken before commencement of long-term
carcinogenicity study, in order to select a non-toxic dose. The
choice of the high dose should be such that it elicits minimal signs
of toxicity but ensures that the test animals have been sufficiently
challenged. In the present study, pan masala was mixed at 5% and
10% dose levels and fed to 10 mice of each sex per dose group for a
period of 8 weeks. Control mice (5 of each sex) were fed normal
diet for the same period. Food consumption was recorded at 24-hr
intervals, 5 days a week, and expressed as mean 6 S.E. For
assessing gross adverse effects, animals were observed weekly for
behavioral and macroscopic changes. Differential leucocyte count
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and estimation of hemoglobin were carried out in each mouse at the
end of the experimental period, when animals were killed by ether
anesthesia. Lung, heart, liver, stomach, esophagus, spleen, pan-
creas, kidney, intestine, urinary bladder and ovaries were routinely
excised, fixed in Bouin’s fluid and processed for histopathology.
No macroscopic, behavioral or clinical abnormalities were
observed in control or in pan-masala-treated animals. The mean
body weight of mice of both sexes fed pan masala at 5% and 10%
levels was similar to that of controls. Food consumption of mice on
5% or 10% pan-masala diet was similar, but significantly lower
than that of controls ( p , 0.001). Thus the mean food consumption
in male control animals and in those receiving 5% and 10%
pan-masala diet was 4.9, 3.8 and 3.6 g/day, while the respective
values in females were 4.4, 3.7 and 3.6 g/day. In spite of the
reduced dietary intake, the mean body weight of mice of both sexes
fed pan masala at 5% and 10% levels for 8 weeks was similar to
that of the respective controls. Histopathologically, all the organs
were essentially normal, although a mild increase in the number of
squamous-cell layers, marked increase in rugosity and keratiniza-
tion, were observed in the forestomach epithelium of pan-masala-
treated animals. These changes were equally marked in animals
feeding on both the doses of pan masala. Mild to moderate
interstitial inflammation of the kidney was noted in a few cases.
Long-term studies using putative carcinogens are generally
conducted at a relatively high exposure level, to maximize the
probability of observing an effect in a relatively small sample of
experimental animals. In this study, the food consumption and
other responses of animals feeding on 5% and 10% pan-masala diet
were similar. However, it was felt that in lifetime-exposure studies,
the higher dose may interfere with nutrition (IARC, 1986). To
avoid such a possibility, instead of MTD (10% dose), 1⁄2 MTD and
1⁄4 MTD were used for carcinogenicity testing.
Sample size. To obtain meaningful biological results, a sufficient
number of animals is needed for the experiment. In determining the
carcinogenicity of a test substance, 2 types of statistical errors are
possible: false-positive (type I) and false-negative (type II), which
need to be minimized. Based on tests of linear trend for 3 equally
spaced doses and fixing the probability values at 0.05 and 0.10 for
type-I and type-II errors respectively, it was estimated that from 70
to a little under 50 animals per group would be needed to detect an
increase in the incidence rate of 0.2 or more in the high-dose group
to a background rate of 0.1 or less. Hence, to allow for logistic and
budgetary constraints on the one hand and meaningful statistical
evaluation of the results on the other, 54 mice of each sex per dose
group were used in the present study. This number would be quite
adequate if the background tumor rate is lower than 5%.
Carcinogenicity experiments. A total of 504 mice (252 of each
sex) were distributed into different cages (5 mice/cage) and
randomly assigned into control (normal diet) and experimental
groups, i.e., diet containing 2.5% and 5% pan masala. In order to
study the progressive pathogenesis of the lesions of interest, 10
mice of each sex/dose group were killed at pre-determined time
points of 6, 12 and 18 months; these are referred to as the
intermediate-exposure group. Blood was collected from the tail
vein of 3 mice of each sex in each of the intermediate-exposure
groups for hematological examination, before the animals were
killed. For the long-term experiments, 54 mice of each sex were fed
normal diet (zero dose) or diet containing pan masala at 2 dose
levels (2.5% and 5%) for the entire lifespan of about 24 months,
and are hereafter referred to as the lifetime-exposure group.
All the animals were observed daily for any abnormalities.
Individual body weight was recorded weekly for the first 8 weeks
and thereafter once every 4 weeks. In the lifetime-exposure group,
mice were killed when grossly moribund or at the termination of
the experiment at 24 months. Necropsy was performed on all the
animals and the tissues (mentioned in the section on dose selection)
were excised, fixed in Bouin’s fluid and processed for routine
histopathology.
Statistical analysis
The log-rank test and Kaplan-Meier graphical output were used
for survival analysis. Since all tumors were observed in the fatal
context, the ‘‘death-rate’’ method was used for comparing site-
specific tumor occurrence in the 3 groups, i.e., controls, 2.5% dose
and 5% dose groups, and tested for positive trend. These trends
were adjusted for sex and intercurrent mortality (Peto et al., 1980).
RESULTS
Intermediate-exposure group
To study progressive pathogenesis of the lesions, 10 male and 10
female mice each belonging to control, 2.5% and 5% dose groups,
i.e., 60 mice per dose group, were killed at 6, 12 and 18 months.
The mean hemoglobin levels 6 S.E. of control mice were 14.2 6
0.9 g% in males and 12.8 6 0.6 g% in females. Hemoglobin levels
and differential leucocyte count were similar in the control and
experimental animals. Non-neoplastic lesions observed in this
group included forestomach hyperplasia in 10 out of 60 mice in the
2.5% dose group and in 5 out of 60 animals in the 5% dose group.
Cystic changes in the ovary were also seen in 2 out of 30 control
females and in 6 out of 60 female mice exposed to pan masala and
killed at 12 and 18 months. No benign or malignant tumors were
detected in the controls or in the tissues of mice exposed to 2.5%
pan masala. However, in the 5% dose group, adenocarcinoma of
the lung was noted in 1 male and 1 female mouse killed at 12 and
18 months respectively.
Lifetime-exposure group
Clinical manifestations such as weakness and lethargy were
observed in older mice of all 3 groups. Data on the body weight for
the control and experimental groups are presented in Figure 1. The
mean body weight of male and female animals fed pan masala at
both the doses was consistently lower than that of the controls, and
the difference was particularly marked from month 6 onwards.
Survival of animals. The survival curves of male and female
mice fed normal and pan-masala-containing diet at both the doses
are shown in Figure 2. The mean survival time for all the animals in
the control, the 2.5% and the 5% pan-masala groups was 18, 17 and
16 months respectively. The log-rank test revealed a significant
decrease in the overall survival rate of mice receiving 2.5% and 5%
pan masala, as compared with the controls whether analyzed with
( p 5 0.02) or without ( p 5 0.02) adjustment for sex. In males, the
mean survival time for both the dose groups was 17 months, as
compared with 19 months in the control group. Similarly, in
females in both the dose groups, the mean survival time was lower
(16 months) than in the controls (18 months).
Histopathological observations. As mentioned earlier, all ani-
mals were subjected to necropsy, and tissues were examined by
histopathology.
Non-neoplastic alterations. A few animals in control and
experimental groups developed pneumonitis (3–9%) and intersti-
tial inflammation of the kidney (4–7%). Ovarian cyst with chronic
inflammatory reaction was noted in 5 (9.2%) of 54 control females
and in 15 (13.9%) of 108 female mice exposed to pan masala.
Cystic change was also observed in the stomach, urinary bladder
and skin of one mouse each receiving lifetime exposure to pan
masala. These lesions were absent in the control animals. Hyperpla-
sia of the forestomach epithelium, the commonest alteration
characterized by basal-cell proliferation and excessive keratiniza-
tion (Fig. 3), was noted in 22 out of 216 pan-masala-treated mice (3
out of 108 animals in the 2.5%-dose group and 19 out of 108 mice
in the 5%-dose group) and none in the controls. Statistical analysis
revealed a significant dose-response relationship in the incidence of
forestomach hyperplasia, (z 5 4.82, p , 0.001 adjusted for sex and
intercurrent mortality).
Neoplastic lesions. Data on benign and malignant tumors
induced in animals receiving lifetime exposure to 2.5% and 5% pan
masala are shown in Table I. No neoplastic lesions were observed
in any of the tissues from control animals, while 15 benign lesions
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and 12 malignant tumors appeared in mice fed pan masala in the
diet. The commonest benign lesion was liver hemangioma, ob-
served in 7 out of 108 mice fed 2.5% pan-masala dose and in 1 out
of 108 animals receiving the 5% dose. The lesion was characterized
by multiple dilated vascular spaces lined by endothelial cells with
normal hepatocytes at the periphery of the lesion (Fig. 4). Other
benign lesions (forestomach papilloma, stomach adenoma, liver
hamartoma and adenoma, and prostate adenoma) appeared in one
mouse each in the 2.5%-dose group, while a liver hamartoma and a
sebaceous-gland skin adenoma were observed in the 5%-dose
group.
Malignant tumors were noted in 5 out of 108 mice fed diet
containing 2.5% pan masala and 7 out of 108 animals receiving 5%
pan masala dose. In the 2.5%-dose group, 1 liver adenocarcinoma,
1 hepatoma and 3 lung adenocarcinomas were seen, while in the
5%-dose group there were 5 adenocarcinomas of the lung and 1
each of forestomach carcinoma and testicular lymphoma. Lung
adenocarcinoma, the most frequent malignant tumor type, was
FIGURE 1 – Mean body weight of male (a) and female (b) S/RVCri
mice fed normal and 2.5%- or 5%-pan-masala-containing diet over a
period of 24 months.
FIGURE 2 – Kaplan-Meier survival curves for male (a) and female
(b) S/RVCri mice in control and experimental groups.
FIGURE 3 – Forestomach hyperplasia. The squamous epithelium
shows basal-cell proliferation and is thrown into folds. Keratinization
is excessive. Scale bar 5 156 µm.
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characterized by columnar cells arranged in acini, with papillary
formations infiltrating the pulmonary parenchyma (Fig. 5). The
number of animals with lung adenocarcinoma exhibited a statisti-
cally significant positive trend with respect to dose (z 5 2.68,
1-tailed p 5 0.004). As seen in Table II, the higher-dose group
showed a 2-fold increase in lung neoplasms as compared with the
low-dose group (ratio of O/E 2.03). Similar analyses of animals
with liver tumors did not yield a significant trend with dose
(z 5 1.38, 1-sided p 5 0.08), nor was there a significant trend for
stomach neoplasms (z 5 1.06, 1-sided p 5 0.15).
DISCUSSION
The essence of the long-term animal bio-assay is to simulate the
human situation wherein neoplastic development due to chronic
exposure to environmental agents is preceded by a long latency
period. In the present study, Swiss mice of S/RVCri strain were
used to evaluate the carcinogenic influence of lifetime exposure to
a popular brand of pan masala which does not contain tobacco,
mainly because these inbred mice are susceptible to tumor develop-
ment by chemical carcinogens (Bhisey et al., 1987). An important
consideration was that spontaneous tumors have not been observed
in this strain during their life span of over 2 years, according to the
records of the Animal Sciences Division at our Institute. This fact
helped to maintain the sample size at a manageable level, while
permitting statistical evaluation of small increases in tumor number
in pan-masala-treated animals.
In order that the route of exposure corresponds to and is as close
as possible to that in the human situation, pan masala was mixed in
the pelleted diet at 2.5% and 5% dose levels. The body weight and
survival rate of animals fed pan masala for their lifetime were
found to be lower than that of the control mice. These changes may
be related to chronic nutritional insufficiency and possibly to liver
toxicity, reported to occur after long-term pan-masala consumption
(Mukherjee et al., 1991). Similar observations have also been
reported by Tanaka et al. (1983) and Rao and Das (1989) in animals
fed diet containing powdered areca nut, the major ingredient of pan
masala. A reduction in body weight was also observed in F344 rats
injected 3-(methylnitrosamino) proprionitrile (MNPN), the areca-
nut-specific carcinogenic nitrosamine (Prokopczyk et al., 1987).
Besides these changes, a dose-dependent increase in the incidence
of focal hyperplasia of the forestomach epithelium was observed in
this study, in mice receiving lifetime exposure to pan masala. This
finding correlates with its forestomach-tumor-promoting activity
noted in our earlier study (Ramchandani et al., 1998). Thus,
lowered body weight and survival rate of S/RVCri mice as well as
induction of forestomach hyperplasia appear to be related to the
consumption of areca nut present in the pan-masala mixture.
Swiss mice used in the present study are occasionally found to
develop cystic ovary and interstitial inflammation in the kidney.
However, no spontaneous tumors have been reported in this mouse
strain to date (Randelia et al., 1983; and data not shown). In this
study too, ovarian cysts were observed both in control and in
pan-masala-treated mice, while no tumors were noted in any of the
tissues from control animals. However, a variety of benign and
TABLE I – SITE-SPECIFIC NEOPLASTIC LESIONS* IN S/RVCri MICE EXPOSED TO
PAN MASALA IN DIET FOR LIFETIME
Treatment
2.5% pan masala 5% pan masala
Male
(n 5 54)
Female
(n 5 54)
Male
(n 5 54)
Female
(n 5 54)
Site and type of lesions
Lung
Adenocarcinoma 3 0 3 2
Liver
Hamartoma 0 1 0 1
Hepatoma 0 1 0 0
Hemangioma 6 1 0 1
Adenoma 1 0 0 0
Adenocarcinoma 0 1 0 0
Forestomach
Papilloma 1 0 0 0
Carcinoma 0 0 1 0
Glandular stomach
Adenoma 0 1 0 0
Testis
Lymphoma 0 0 1 0
Prostate
Adenoma 1 0 0 0
Skin
Sebaceous adenoma 0 0 1 0
*No neoplastic lesions were observed in the control group compris-
ing 54 male and 54 female mice.
FIGURE 4 – Liver hemangioma. Multiple dilated, endothelial-lined
vascular spaces are seen ramifying between normal hepatocytes. Scale
bar 5 50 µm.
FIGURE 5 – Lung adenocarcinoma. Papillary structures lined by
columnar cells are seen infiltrating the pulmonary parenchyma. Scale
bar 5 98 µm.
TABLE II – LUNG ADENOCARCINOMAS*: OBSERVED NUMBERS AND
EXPECTED NUMBERS ADJUSTED FOR SEX AND INTERCURRENT MORTALITY
Treatment group Observed (O) Expected (E) O/E
Control 0 3.2183 0
2.5% dose 3 2.6258 1.14
5% dose 5 2.1559 2.32
*All tumors observed in the fatal context.
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malignant tumors were induced in different tissues of animals
given 2.5% and 5% doses of pan masala throughout their life span.
Neoplastic lesions were induced mainly in the liver (n 5 13),
lung (n 5 8) and stomach (n 5 3), and 1 neoplasm each also
appeared in the prostate, testes and skin of mice in the lifetime-
exposure group. Of these lesions, 12 were malignant, the most
frequent being lung adenocarcinoma, observed in 8 mice followed
by one each of liver adenocarcinoma, hepatoma stomach carci-
noma and testicular lymphoma. These findings indicate that liver,
lung and stomach are the target tissues for carcinogenic action of
pan masala. However, unlike the lung, where a dose-response
relationship was observed, such an increase with dose was not
observed in the case of stomach tumors and liver neoplasms. In
earlier studies, induction of liver hemangioma, hepatoma, forestom-
ach carcinoma and lung adenocarcinoma was reported in Swiss
mice given s.c. injections of an aqueous areca nut extract or
polyphenolic fraction of areca nut (Bhide et al., 1979; Shivapurkar
et al., 1980). Forestomach papillomas were also observed in Syrian
hamsters and ACI rats fed powdered areca nut or areca nut and lime
respectively in the diet, for most of their life span (Tanaka et al.,
1983; Ernst et al., 1987). However, in these studies, tumor-
induction data were not analyzed statistically presumably due to
small sample size. A dose-dependent increase in lung adenocarci-
noma observed in the present study indicates that pan masala exerts
maximum carcinogenic influence in the lung tissue. This inference
is strengthened by the appearance of 2 lung adenocarcinomas in the
intermediate-exposure group in mice fed high dose (5%) of pan
masala and killed at pre-determined time points of 12 and 18
months.
In humans, oral tumors generally develop at sites in direct
contact with tobacco/areca nut containing chewing products.
Differences in the mode of pan-masala exposure may contribute to
differences in the target site of humans and experimental animals.
However, differences in the expression of catalytic activities and
substrate specificities of cytochrome P450 enzymes in rodents and
man (Nebert et al., 1991) may also be responsible for tumor
occurrence at sites different from those in man.
Chemical analysis has revealed that pan-masala mixture contains
polycyclic aromatic hydrocarbons, nitrosamines, toxic metals and
residual pesticides (Kashyap et al., 1989). Similar analysis from
our laboratory has revealed the presence of volatile aldehydes
including formaldehyde, acrolein, crotonaldehyde, propionalde-
hyde and isobutaraldehyde in pan masala without tobacco (data not
shown). Some of these aldehydes are known to be carcinogenic in
rats, producing tumors in the liver and nasal mucosa (IARC, 1987).
Areca nut, the major component of pan masala, is composed of
tannins, fats, free fatty acids, polysaccharides, crude fibers and
minerals, and has at least 6 reduced pyridine alkaloids, namely,
arecoline, arecaidine, arecolidine, guvacoline, guvacine and isogu-
vacine (Ashby et al., 1979; Majumdar et al., 1979). Some of these
alkaloids are converted to carcinogenic nitrosamines in mild
nitrosation conditions (Nair et al., 1985) and have been detected in
the saliva of betel-quid chewers. Prokopczyk et al. (1987) found
that MNPN is metabolically activated to diazomethane and acrylo-
nitrile, which are capable of alkylating DNA. In addition, arecaid-
ine may undergo epoxidation at alkaline pH to give rise to
carcinogenic 3,4-epoxide (Panigrahi and Rao, 1984). Lime, another
component of pan masala, could conceivably act by generation of
reactive oxygen species, which are implicated in the carcinogenic
process (Nair et al., 1992), while catechu is known to liberate
tannins which are genotoxic (IARC, 1985). Thus, it appears that the
induction of histogenetically distinct lesions in different organs of
mice in the present study can be attributed to various carcinogens
and their derivatives present in the pan-masala mixture. However,
it is not possible to specify individual carcinogens that may be
responsible for the development of different tumors.
A causal association appears to exist between the habit of
chewing pan masala and early onset of oral submucous fibrosis, a
condition known to predispose to malignancy (Babu et al., 1996).
We have reported that pan masala exhibits tumor-promotor and
-progressor activity in mouse skin, stomach and esophagus (Ram-
chandani et al., 1998). In the present study, we have provided
unequivocal evidence regarding carcinogenicity of pan masala in
different tissues, and particularly in the lung of S/RVCri mice.
Taken together, our findings strongly indicate that pan masala, a
chewing product without tobacco, should be considered as a
potential human carcinogen.
ACKNOWLEDGEMENTS
The technical assistance of Mr. M.L. Jagtap in animal house
work, Mr. P.S. Chavan and Mr. V.M. Sakpal in histological
preparations, Mr. V.V. Pimpalkhare in typing of the manuscript, and
the staff of the Animal House is gratefully acknowledged. Thanks
are due to Mr. S.G. Rayabhattanavar of the Clinical Research
Secretariat, Tata Memorial Hospital, Mumbai, India, for assistance
with data processing.
REFERENCES
ADHVARYU, S.G., DAVE, B.J. and TRIVEDI, A.H., An in vitro assessment of
the genotoxic potential of pan masala. Indian J. med. Res., 90, 131–134
(1989).
ANURADHA, C.D. and DEVI, C.S., Serum protein, ascorbic acid and iron and
tissue collagen in oral sub-mucous fibrosis—a preliminary study. Indian J.
med. Res., 98, 147–151 (1993).
ASHBY, J., STYLES, J.A. and BOYLAND, E., Betel nuts, arecaidine and oral
cancer. Lancet, i, 112 (1979).
BABU, S., BHAT, R.V., KUMAR, P.U., SESIKARAN, B., RAO, K.V., ARUNA, P.
and REDDY, P.R., A comparative clinico-pathological study of oral sub-
mucous fibrosis in habitual chewers of pan masala and betel quid. J.
Toxicol. clin. Toxicol., 34, 317–322 (1996).
BAGWE, A.N., GANU, U.K., GOKHALE, S.V. and BHISEY, R.A., Evaluation of
the mutagenicity of ‘‘pan masala,’’ a chewing substitute widely used in
India. Mutation Res., 241, 349–354 (1990).
BHIDE, S.V., SHIVAPURKAR, N.M., GOTHOSKAR, S.V. and RANADIVE, K.J.,
Carcinogenicity of betel-quid ingredients: feeding mice with aqueous
extracts and the polyphenol fraction of betel nut. Brit. J. Cancer, 40,
922–926 (1979).
BHISEY, R.A., VETURKAR, P.L. and BORGES, A.M., Comparison of the
sensitivity of Swiss albino and hairless Swiss bare mice to two-stage skin
tumorigenesis. Indian J. exp. Biol., 25, 90–96 (1987).
CHIN, C.T. and LEE, K.W., The effects of betel-nut chewing on the buccal
mucosa of 296 Indians and Malaysians in West Malaysia, a clinical study.
Brit. J. Cancer, 24, 427–432 (1970).
DAVE, B.J., TRIVEDI, A.H. and ADHVARYU, S.G., Cytogenetic studies reveal
increased genomic damage among ‘‘pan masala’’ consumers. Mutagenesis,
6, 159–163 (1991).
DAVE, B.J., TRIVEDI, A.H. and ADHVARYU, S.G., In vitro genotoxic effects of
areca-nut extract and arecoline. J. Cancer Res. clin. Oncol., 118, 283–288
(1992).
DUNHAM, L.J., MUIR, C.S. and HAMNER, J.E. III, Epithelial atypia in hamster
cheek pouches treated repeatedly with calcium hydroxide. Brit. J. Cancer,
20, 588–593 (1966).
ERNST, H., OHSHIMA, H., BARTSCH, H., MOHR, U. and REICHART, P.,
Tumorigenicity study in Syrian hamsters fed areca nut together with nitrite.
Carcinogenesis, 8, 1843–1845 (1987).
GIRI, A.K., BANERJEE, T.S., TALUKDAR, G. and SHARMA, A., Induction of
sister-chromatid exchange and dominant lethal mutation by Katha (catechu)
in male mice. Cancer Lett., 36, 189–196 (1987).
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, Tobacco habits other
than smoking: betel-quid and areca-nut chewing and some related nitrosa-
mines. IARC Monographs on the evaluation of carcinogenic risk of
chemicals to humans, Vol. 37, pp. 141–202, IARC, Lyon (1985).
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, Bioassay for carcinoge-
nicity in animals. In: R. Montesano, H. Bartsch, H. Vainio, J. Wilbourn and
H. Yamasaki (eds.), Long-term and short-term assays for carcinogens: a
critical appraisal. IARC Scientific Publication 83, pp. 13–83, IARC, Lyon
(1986).
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER, Overall evaluations of
683LONG-TERM CARCINOGENICITY OF PAN MASALA
carcinogenicity: An updating of IARC monographs Vols. 1 to 42. IARC
Monographs on the evaluation of carcinogenic risk of chemicals to human,
Suppl. 7, IARC, Lyon (1987).
KASHYAP, S.K., NIGAM, S.K., KARNIK, A.B., PATEL, T.S., RASTOGI, P.B.,
LAKKAD, B.C. and KUMAR, A., Toxicological evaluation of pan masala.
Annual Report of NIOH for the year 1989–90, pp. 60–66, National Institute
of Occupational Health, Ahmedabad (1989).
MAJUMDAR, A.M., KAPADIA, A.H. and PENDSE, G.S., Chemistry and
pharmacology of betel nut Areca catechu Linn. J. Plant Crops. 7, 69–92
(1979).
MUKHERJEE, A., CHAKRABARTI, J., CHAKRABARTI, A., BANERJEE, T. and
SHARMA, A., Effect of pan masala on the germ cells of male mice. Cancer
Lett., 58, 161–165 (1991).
MUKHERJEE, A. and GIRI, A.K., Sister chromatid exchange induced by pan
masala (a betel-quid ingredient) in male mice in vivo. Food Chem. Toxicol.,
29, 401–403 (1991).
NAIR, J., OHSHIMA, H., FRIESEN, M., CROISSY, A., BHIDE, S.V. and BARTSCH,
H., Tobacco-specific and betel-nut-specific N-nitroso compounds: occur-
rence in saliva and urine of betel-quid chewers and formation in vitro by
nitrosation of betel quid. Carcinogenesis, 6, 296–303 (1985).
NAIR, U.J., OBE, G., FRIESEN, M., GOLDBERG, M.T. and BARTSCH, H., Role
of lime in the generation of reactive oxygen species from betel-quid
ingredients. Environ. Hlth. Perspect., 98, 203–205 (1992).
NEBERT, D.W. and 13 OTHERS, The P450 superfamily: update on new
sequences, gene mapping and recommended literature. DNA Cell Biol., 10,
1–14 (1991).
PANIGRAHI, G.B. and RAO, A.R., Induction of in vivo sister-chromatid
exchanges by arecaidine, a betel-nut alkaloid, in mouse bone-marrow cells.
Cancer Lett., 23, 189–192 (1984).
PANIGRAHI, G.B. and RAO, A.R., Study of the genotoxicity of the total
aqueous extract of betel nut and its tannin. Carcinogenesis, 7, 37–39 (1986).
PETO, R., PIKE, M.C., DAY, N.E., GRAY, R.G., LEE, P.N., PARISH, S., PETO, J.,
RICHARDS, S. and WAHRENDORF, J., Guidelines for simple, sensitive
significance tests for carcinogenic effects in long-term animal experiments.
In: Long-term and short-term assays for carcinogens: a critical appraisal.
IARC Monograph supplement 2, pp. 311–426, IARC, Lyon (1980).
POLASA, K., BABU, S. and SHENOLIKAR, I.S., Dose-dependent genotoxic
effect of pan masala and areca nut in the Salmonella typhimurium assay.
Food Chem. Toxicol., 31, 439–442 (1993).
PROKOPCZYK, B., RIVERSON, A., BERTINATO, P., BRUNNEMANN, K.D. and
HOFFMANN, D., 3-(methylnitrosamino)propionitrile: occurrence in saliva of
betel-quid chewers, carcinogenicity and DNA methylation in F344 rats.
Cancer Res., 47, 467–471 (1987).
RAMCHANDANI, A.G., D’SOUZA, A.V., BORGES, A.M. and BHISEY, R.A.,
Evaluation of carcinogenic/co-carcinogenic activity of a common chewing
product, pan masala in mouse skin, stomach and esophagus. Int. J. Cancer,
75, 225–232 (1998).
RANADIVE, K.J., GOTHOSKAR, S.V., RAO, A.R., TEZABWALLA, B.V. and
AMBAYE, R.Y., Experimental studies on betel nut and carcinogenicity. Int. J.
Cancer, 17, 469–476 (1976).
RANDELIA, H.P., HILGERS, J., HILKENS, J., KROEZEN, V., HOLMES, R. and
VANDEBERG, J., Genetic marker patterns of inbred strains of mice at the
Cancer Research Institute, Bombay. Lab. Animals, 17, 280–284 (1983).
RAO, A.R. and DAS, P., Evaluation of the carcinogenicity of different
preparations of areca nut in mice. Int. J. Cancer, 43, 728–732 (1989).
SARMA, A.B., CHAKRABARTI, J., CHAKRABARTI, A., BANERJEE, T.S., ROY, D.,
MUKHERJEE, D. and MUKHERJEE, A., Evaluation of pan masala for toxic
effects on liver and other organs. Food Chem. Toxicol., 30, 161–163 (1992).
SHIVAPURKAR, N.M., RANADIVE, S.N., GOTHOSKAR, S.V., BHIDE, S.V. and
RANADIVE, K.J., Tumorigenic effect of aqueous and polyphenolic fractions
of betel nut in Swiss-strain mice. Indian J. exp. Biol., 18, 1159–1161
(1980).
SINOR, P.N., GUPTA, P.C., MURTI, P.R., BHONSLE, R.B., DAFTARY, D.K.,
MEHTA, F.S. and PINDBORG, J.J., A case-control study of oral sub-mucous
fibrosis with special reference to the etiologic role of areca nut. J. oral
Pathol. Med., 19, 94–98 (1990).
STICH, H.F., BOHM, B.A., CHATTERJEE, K. and SAILO, J.L., The role of
saliva-borne mutagens and carcinogens in the etiology of oral and
esophageal carcinomas of betel-nut and tobacco chewers. In: H.F. Stich
(ed.), Carcinogens and mutagens in the environment, Vol. II, Naturally
occurring compounds, pp. 43–58, CRC Press, Boca Raton, FL (1983).
SURI, K., GOLDMAN, M.H. and WELLS, H., Carcinogenic effect of a
dimethyl-sulphoxide extract of betel nut on mucosa of hamster buccal
pouch. Nature (Lond.), 230, 383–384 (1971).
TANAKA, T., MORI, H., FUJI, M., TAKAHASHI, M. and HIRONO, I., Carcinoge-
nicity examination of betel quid. II. Effect of vitamin-A deficiency on rats
fed semi-purified diet containing betel nut and calcium hydroxide. Nutr.
Cancer, 4, 260–266 (1983).
684 BHISEY ET AL.
